Business and Financial Services Public Relations
Business Software and Solutions Public Relations
Cleantech and Green Public Relations
Consumer Public Relations
Data Center and IT Operations Public Relations
Emerging Technology Public Relations
Healthcare IT Public Relations
Medical Device and Diagnostics Public Relations
Networking, Wireless and Telecom Public Relations
Pharmaceutical and Biotech Public Relations
Security Public Relations
Software Development and Open Source Public Relations
Industry Expertise

Pharmaceutical and Biotech Public Relations

Recent Pharmaceutical and Biotech Public Relations Coverage
The Scientist
The cover story in the May issue of The Scientist is a feature contributed by our client Absorption Systems. The article is about drug-drug interactions and how the pharmaceutical industry needs to better understand how drugs taken in combination can have unintended effects. Absorption Systems is a CRO that tests how your body absorbs, distributes, metabolizes and excretes (ADME) drugs. They also do toxicology testing for drugs and devices. Link to Article
Wall Street Journal
Following the close of more than $75M in funding, this article examines Micromet's strong clinical data for the company's novel antibody technology. Known as BiTE, these antibodies engage T- cells in order to seek out and destroy cancer anywhere in the body. The article outlines the company's impressive clinical progress for lead drug candidate MT103, currently being tested in patients with acute lymphoblastic leukemia and non-Hodgkin's lymphoma. The article also includes several quotes from investors and analysts on Micromet's attractiveness as a potential acquisition target.

Biotech, pharmaceutical and molecular medicine companies turn to Schwartz to enhance their market positions and brands through thoughtful strategy and creative public relations programs. From discovery to development to commercialization, Schwartz is uniquely able to provide PR services to a broad range of life sciences firms. We translate the science into stories that resonate with broad audiences by working intelligently with researchers, compassionately with patients and proactively with the media.

Just as superior science provides the competitive advantage for pharmaceutical and biotech companies, choosing the right life sciences PR agency can be the critical difference between marketing failure and success. Schwartz has perfected the science of media relations and orchestrates national PR campaigns that achieve objectives such as product and technology visibility, partnership and funding cultivation, clinical trial recruitment, pre-launch market conditioning, new product introductions, reimbursement advocacy, alliance-building and paving the way for successful liquidity events.

In addition to award-winning media relations and social media capabilities, we offer outstanding complementary services such as government relations/public affairs, media coaching, video production and a speakers’ bureau.

Schwartz has a track record of working with some of the most innovative companies in the life sciences sector to publicize their science, products and people. Both past and present, representative clients include emerging as well as established organizations such as Cepheid, PowderMed (acquired by Pfizer), Osiris Therapeutics, BayBio, Micromet, StemCells, Biogen, Caliper Life Sciences, BioMS Medical, Agencourt (acquired by Beckman Coulter), Southern Research Institute and West Pharmaceutical Services.

Information about our work with biotech-based diagnostics companies and with other healthcare organizations is available here. We look forward to hearing from you about your company’s PR requirements.



Related Case Studies
HTG
Agencourt Bioscience Corporation
InnoCentive

Our Pharmaceutical and Biotech Public Relations Clients

 


US
UK
SWEDEN